HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
H W Verspaget Selected Research
H W Verspaget Research Topics
Disease
7
Neoplasms (Cancer)
07/2016 - 08/2000
6
Stomach Neoplasms (Stomach Cancer)
07/2016 - 08/2000
5
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
09/2014 - 12/2002
4
Colorectal Neoplasms (Colorectal Cancer)
02/2009 - 01/2000
4
Crohn Disease (Crohn's Disease)
08/2007 - 12/2001
3
Clostridium Infections
03/2021 - 12/2017
2
Disease Susceptibility (Diathesis)
03/2009 - 09/2006
2
Adenocarcinoma
02/2009 - 08/2000
2
Ulcerative Colitis
08/2007 - 08/2005
2
Inflammation (Inflammations)
08/2005 - 12/2002
2
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
10/2001 - 12/2000
1
Melanoma (Melanoma, Malignant)
12/2022
1
Rheumatoid Arthritis
01/2016
1
Autoimmune Hepatitis
06/2015
1
Colitis
09/2014
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
10/2011
1
Carcinoid Tumor (Carcinoid)
10/2011
1
Fibrosis (Cirrhosis)
08/2007
1
Achlorhydria (Hypochlorhydria)
02/2006
1
Typhoid Fever (Typhoid)
02/2006
1
Fistula
09/2004
1
Necrosis
09/2004
1
Ischemia
12/2003
1
Reperfusion Injury
12/2003
1
Ovarian Neoplasms (Ovarian Cancer)
12/2000
1
Ovarian Epithelial Carcinoma
12/2000
1
Gastrointestinal Neoplasms (Gastrointestinal Cancer)
11/2000
1
Metaplasia
11/2000
1
Carcinoma (Carcinomatosis)
08/2000
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2000
1
Esophageal Neoplasms (Esophageal Cancer)
08/2000
Drug/Important Bio-Agent (IBA)
6
Matrix Metalloproteinases (MMPs)
IBA
04/2012 - 12/2003
4
Proteins (Proteins, Gene)
FDA Link
01/2016 - 08/2005
3
Antioxidants
IBA
12/2002 - 08/2000
2
Tissue Inhibitor of Metalloproteinase-1
IBA
09/2006 - 04/2006
2
Enzymes
IBA
04/2006 - 08/2005
2
Immunosorbents
IBA
04/2006 - 08/2005
2
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
04/2006 - 08/2005
2
Infliximab (Remicade)
FDA Link
09/2004 - 12/2001
2
Superoxide Dismutase
IBA
10/2001 - 08/2000
2
Metallothionein
IBA
12/2000 - 11/2000
1
Immune Checkpoint Inhibitors
IBA
12/2022
1
Biocompatible Materials (Biomaterials)
IBA
07/2016
1
Antibodies
IBA
01/2016
1
HLA-DRB1*03:01 antigen
IBA
06/2015
1
HLA Antigens (Human Leukocyte Antigens)
IBA
06/2015
1
HLA-DRB1*04:01 antigen
IBA
06/2015
1
Toll-Like Receptor 6
IBA
09/2014
1
Conditioned Culture Media
IBA
01/2014
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
01/2014
1
Plasminogen Activator Inhibitor 1
IBA
01/2014
1
Peptide Hydrolases (Proteases)
FDA Link
01/2014
1
Peptides (Polypeptides)
IBA
10/2011
1
Bombesin Receptors (Bombesin Receptor)
IBA
10/2011
1
Gastrin-Releasing Peptide
IBA
10/2011
1
Bombesin
IBA
10/2011
1
Ligands
IBA
10/2011
1
neuromedin B
IBA
10/2011
1
Interleukin-23 (Interleukin 23)
IBA
03/2009
1
Nucleotides
IBA
03/2009
1
Transcription Factors (Transcription Factor)
IBA
02/2009
1
Transforming Growth Factor beta1 (TGF beta 1)
IBA
08/2007
1
Tissue Inhibitor of Metalloproteinases
IBA
08/2007
1
Matrix Metalloproteinase 1 (Interstitial Collagenase)
IBA
08/2007
1
Peroxidase (Myeloperoxidase)
IBA
08/2007
1
Matrix Metalloproteinase 7 (Matrilysin)
IBA
07/2007
1
Antigens
IBA
09/2006
1
Immunoglobulin G (IgG)
IBA
02/2006
1
Immunoglobulin A (IgA)
IBA
02/2006
1
Gastrins
IBA
02/2006
1
Matrix Metalloproteinase 9 (Gelatinase B)
IBA
08/2005
1
Messenger RNA (mRNA)
IBA
08/2005
1
Fibroblast Growth Factors (Fibroblast Growth Factor)
IBA
09/2004
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
09/2004
1
Oxygen (Dioxygen)
IBA
12/2002
1
Superoxide Dismutase-1
IBA
12/2000
1
Platinum
IBA
12/2000
1
Metalloproteins
IBA
11/2000
1
Oxidants (Oxidizing Agents)
IBA
08/2000
1
Zinc
IBA
08/2000
1
Superoxides (Superoxide)
IBA
08/2000
1
Copper
IBA
08/2000
1
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
01/2000
Therapy/Procedure
4
Therapeutics
12/2022 - 08/2000
3
Fecal Microbiota Transplantation
12/2022 - 01/2019
1
Transplantation
12/2017
1
Neoadjuvant Therapy
07/2016
1
Liver Transplantation
12/2003
1
Drug Therapy (Chemotherapy)
12/2000
1
Chemoprevention
01/2000